Navigation Links
In vitro study finds digested formula, but not breast milk, is toxic to cells
Date:12/10/2012

Free fatty acids created during the digestion of infant formula cause cellular death that may contribute to necrotizing enterocolitis, a severe intestinal condition that is often fatal and occurs most commonly in premature infants, according to a study by University of California, San Diego bioengineers. Their report, which was based on in vitro tests comparing the digestion of fresh human breast milk and nine different infant formulas, was published online in the journal Pediatric Research.

Scientists have long known that premature infants fed formula are more likely to develop necrotizing enterocolitis than those fed breast milk. The condition is the leading cause of death from gastrointestinal diseases in premature infants, but the underlying mechanism has not been understood. Alexander Penn, a research scientist working in the Microcirculation Laboratory of bioengineering Professor Geert Schmid-Schnbein from the UC San Diego Jacobs School of Engineering, believes they have come closer to an answer.

Penn and others had previously determined that the partially digested food in a mature, adult intestine is capable of killing cells, due to the presence of free fatty acids which have a "detergent" capacity that damages cell membranes. The intestines of healthy adults and older children have a mature mucosal barrier that may prevent damage due to free fatty acids. However, the intestine is leakier at birth, particularly for preterm infants, which could be why they are more susceptible to necrotizing enterocolitis.

Therefore, the researchers wanted to know what happens to breast milk as compared to infant formula when they are exposed to digestive enzymes. They "digested," in vitro, infant formulas marketed for full term and preterm infants as well as fresh human breast milk using pancreatic enzymes or fluid from an intestine. They then tested the formula and milk for levels of free fatty acids. They also tested whether these
'/>"/>

Contact: Catherine Hockmuth
chockmuth@ucsd.edu
858-822-1359
University of California - San Diego
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Case Western Reserve researchers create short-term memories in-vitro
2. In vitro studies assess the optimal concentration of propolis as a radioprotector
3. BUSM in vitro study identifies potential combination therapy for breast cancer
4. New Blood Thinner May Help Prevent Leg Clots, Study Finds
5. Minimal Exercise Protects Senior’s Hearts According to Recent Study Reviewed By Projects for Natural Health Choices Inc.
6. Study finds association between oxygen deprivation before birth and ADHD
7. Brain study shows why some people are more in tune with what they want
8. VABC Responds to Study on Use of Cholesterol Lowering Drug Statins on Cancer Patients
9. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
10. Too Little Sleep Spurs Appetite-Boosting Hormones: Study
11. Funding Meals on Wheels Keeps Seniors Independent: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
In vitro study finds digested formula, but not breast milk, is toxic to cells
(Date:9/1/2015)... ... September 01, 2015 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for the European Union. Leading companies ... their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... back pain – once required a long, arduous recovery. However, today’s minimally invasive ... pain, less blood loss and minimal muscle damage. These advantages of minimally invasive ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental clinicians from Newcastle University, ... Sciences to learn more about its integrated approach to diabetes care. , Philip ... of Cellular Medicine at Newcastle University, and Susan Bissett, National Institute for Health ...
(Date:8/31/2015)... ... August 31, 2015 , ... Wound Care Advantage, a ... second Introduction to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to ... Hotel in Long Beach, CA. The meeting is open for registration from physicians, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... President, Marketing and Corporate Communications. In this capacity, Michael will provide strategic leadership ... an industry leader in consumer-focused programs that have contributed to the company’s rapid ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2
... of adenocarcinoma of the esophagus (or gullet) has been on ... treatment are improving the outlook for patients. In the current ... Int 2011; 108[18]: 313𔃇), Angelika Behrens and her working ... main cause of this cancer is reflux of gastric acid ...
... HILL, N.C. By the age of 20, most people have ... it was assumed that skeletal enlargement elsewhere in the body also ... at the University of North Carolina at Chapel Hill has found ... ("hipbones") does continue to widen as people advance in age from ...
... Phase III study presented today at the EULAR 2011 Annual ... who had previously not responded to treatment with DMARDs, achieved ... with the novel oral Janus kinase inhibitor tofacitinib at 10mg ... improvements were also observed in the 5 mg BID dose. ...
... tend to have lower earnings and labor force participation ... disability benefits, a new study finds. Rejected applicants ... accepted applicants, according to the research led by economist ... average, the study found, those rejected for benefits made ...
... , TUESDAY, May 24 (HealthDay News) -- Drug company marketing ... students, ethical judgment, researchers warn. A team led by ... in Boston analyzed published studies that included a total of ... The investigators found that most of the students had some ...
... Clinical trials for a new bladder cancer therapy show ... the breakthrough using the drug Urocidin follows thirty years ... am optimistic about the results of the trial," says ... at Queen,s University and director of the Queen,s University ...
Cached Medicine News:Health News:Pelvic widening continues throughout a person's lifetime, UNC study 2Health News:US study shows that tofacitinib is an efficacious treatment for active RA 2Health News:Study finds much different work histories for disability rejects, beneficiaries 2Health News:Drug Marketing Often Targets Med Students: Analysis 2Health News:New made-in-Canada therapy for bladder cancer shows promising results 2
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, Inc. ... biopharmaceutical company developing products that address unmet medical ... biodefense, announced today it has completed enrollment of ... Review Committee (DRC) earlier this year, into the ... a first-in-class innate defense regulator (IDR) and is ...
(Date:8/31/2015)... Aug. 31, 2015  QT Vascular Ltd., together with its ... with its subsidiaries, the "Group"), a global company ... advanced therapeutic solutions for the minimally invasive treatment ... of the below-the-knee ("BTK") cohort of patients in ... presented on August 15, 2015 at the 5th ...
(Date:8/30/2015)... y LONDRES, August 30, 2015 ... holística de l cuidado al paciente ... trayecto   Royal Philips  ... europeo de IntelliSpace Cardiovascular , un sistema web ... herramientas para acceder, analizar y compartir imágenes cardiovasculares e ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... Austria AG for the co-development and manufacture of ... The agreement combines Sony DADC,s premier Blu-ray Disc™ ...
... Nov. 3, 2010 Cyberonics, Inc. (Nasdaq: CYBX ) ... second quarter ended October 29, 2010 of its fiscal year ending ... ET.  The company will conduct a conference call to discuss those ... Fiscal Year 2011 Second Quarter Results Conference Call InstructionsTo ...
Cached Medicine Technology:Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This instrument can be used as a spoon forceps in gynecologic surgery....
This is a single-action instrument that features a spring handle....
Medicine Products: